Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Dickhoff

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancerIlias Houda, Idris Bahce, Chris Dickhoff, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
The Lancet. Respiratory Medicine|April 19, 2024
Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trialKirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, et al.
JTO Clinical and Research Reports|September 30, 2021
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter AnalysisMerle I Ronden, Idris Bahce, Niels J M Claessens, et al.
JAMA Surgery|June 25, 2025
Intercostal or Paravertebral Block vs Thoracic Epidural in Lung Surgery: A Randomized Noninferiority TrialLouisa N Spaans, Marcel G W Dijkgraaf, Denis Susa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2019
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation CarriersKoen M A Dreijerink, Johannes A Rijken, C J Compaijen, et al.
The Lancet. Respiratory Medicine|March 27, 2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaborationAnne-Marie C Dingemans, Isabelle Opitz, Alessandro Brunelli, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer GroupMariana Brandão, Elena Prisciandaro, Eleni Xenophontos, et al.
Calcified Tissue International|November 13, 2024
Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis ImperfectaLuca Celli, Mark R Garrelfs, Ralph J B Sakkers, et al.
Frontiers in Endocrinology|August 28, 2020
Collaboration Around Rare Bone Diseases Leads to the Unique Organizational Incentive of the Amsterdam Bone CenterElisabeth M W Eekhoff, Dimitra Micha, Tymour Forouzanfar, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancerIlias Houda, Idris Bahce, Chris Dickhoff, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
The Lancet. Respiratory Medicine|April 19, 2024
Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trialKirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, et al.
JTO Clinical and Research Reports|September 30, 2021
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter AnalysisMerle I Ronden, Idris Bahce, Niels J M Claessens, et al.
JAMA Surgery|June 25, 2025
Intercostal or Paravertebral Block vs Thoracic Epidural in Lung Surgery: A Randomized Noninferiority TrialLouisa N Spaans, Marcel G W Dijkgraaf, Denis Susa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2019
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation CarriersKoen M A Dreijerink, Johannes A Rijken, C J Compaijen, et al.
The Lancet. Respiratory Medicine|March 27, 2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaborationAnne-Marie C Dingemans, Isabelle Opitz, Alessandro Brunelli, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer GroupMariana Brandão, Elena Prisciandaro, Eleni Xenophontos, et al.
Calcified Tissue International|November 13, 2024
Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis ImperfectaLuca Celli, Mark R Garrelfs, Ralph J B Sakkers, et al.
Frontiers in Endocrinology|August 28, 2020
Collaboration Around Rare Bone Diseases Leads to the Unique Organizational Incentive of the Amsterdam Bone CenterElisabeth M W Eekhoff, Dimitra Micha, Tymour Forouzanfar, et al.
Pageof 9